PUBLISHER: TechNavio | PRODUCT CODE: 1083100
PUBLISHER: TechNavio | PRODUCT CODE: 1083100
Technavio has been monitoring the cardiac monitoring and cardiac rhythm management devices market and it is poised to grow by $ 5.52 bn during 2022-2026, accelerating at a CAGR of 4.5% during the forecast period. Our report on the cardiac monitoring and cardiac rhythm management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of CVDs, technological advances, and the increasing uptake of mobile cardiac telemetry (MCT).
The cardiac monitoring and cardiac rhythm management devices market analysis includes product segment and geographic landscape.
Technavio's cardiac monitoring and cardiac rhythm management devices market is segmented as below:
By Product
By Geographical Landscape
This study identifies the increasing r&d focus as one of the prime reasons driving the cardiac monitoring and cardiac rhythm management devices market growth during the next few years. Also, the growing focus on the development of integrated arrhythmia monitoring devices and increasing utilization of cardiac implants will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the cardiac monitoring and cardiac rhythm management devices market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiac monitoring and cardiac rhythm management devices market vendors that include Abbott Laboratories, Abiomed Inc., ACS Diagnostics Inc., Asahi Kasei Corp., BioTelemetry Inc., BIOTRONIK SE, and Co KG, Boston Scientific Corp., Fukuda Denshi Co. Ltd., GE Healthcare Inc., HILL ROM HOLDINGS Inc., InfoBionic Inc., Integrated Sensing Systems Inc., iRhythm Technologies Inc., Koninklijke Philips NV, Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., OSI Systems Inc., Preventice Solutions Inc., and SCHILLER AG. Also, the cardiac monitoring and cardiac rhythm management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: